Proximagen program for treatment of neurological disorders

Saniona has entered into a drug discovery and development collaboration with Upsher-Smith Laboratories through its wholly-owned UK subsidiary Proximagen. The collaboration focuses on research of new small molecule therapeutics for neurological disorders, using Saniona’s expertise in ion channels and related technology platforms. The program is in the drug discovery phase.